Wikidata

(Q62809138)

English

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

clinical trial

In more languages

Statements

title
A Phase 2B Randomized Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis (English)
0 references
country
Canada
0 references
Japan
0 references
start time
4 May 2018
0 references
end time
16 January 2020
0 references
number of participants
160
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62809138&oldid=2118982659"